Machine Learning-Based Classification of BI-RADS 4 and BI-RADS 5 Microcalcifications in Mammography Combined with DCE-MRI for Malignant-Benign Discrimination.
Authors
Affiliations (2)
Affiliations (2)
- Department of Radiology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir 35360, Turkey.
- Cloud Computing Operators, Isparta School of Information Technologies, Isparta University of Applied Sciences, Isparta 32200, Turkey.
Abstract
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Early and accurate characterization of suspicious mammographic microcalcifications is essential for improving diagnostic decision-making and reducing unnecessary invasive procedures. Microcalcifications classified as BI-RADS 4 and BI-RADS 5 are clinically important radiological findings; however, differentiating benign from malignant lesions remains challenging because of overlapping morphological and distribution patterns. This study aimed to develop a structured feature-based machine learning model for predicting the pathological diagnosis of breast microcalcifications by integrating mammographic descriptors, patient age, and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) contrast enhancement findings. The dataset included 53 biopsy-confirmed cases and consisted of clinical and radiological variables, including patient age, calcification morphology, calcification size, distribution pattern, DCE-MRI contrast enhancement status, and histopathological outcome. Several conventional machine learning algorithms were evaluated, including Logistic Regression, Support Vector Machine with radial basis function kernel, K-Nearest Neighbors, Decision Tree, Random Forest, Extra Trees, Gradient Boosting, AdaBoost, and CatBoost. Hyperparameter optimization was performed using grid search with five-fold cross-validation. Model performance was assessed using accuracy, precision, recall, F1-score, ROC-AUC, and log loss. Logistic Regression achieved the highest overall performance, with an accuracy of 0.909 and an F1-score of 0.889, while AdaBoost achieved a recall of 1.000 in the internal evaluation. However, given the limited sample size and lack of external validation, these findings should be interpreted as preliminary. The results suggest that structured radiological descriptors combined with DCE-MRI enhancement information may support malignancy risk stratification of BI-RADS 4-5 microcalcifications, although larger multicenter studies are required before clinical implementation.